DIATER

Allergy diagnosis & molecular immunotherapy

DIATER

Biopharmaceutical solutions spanning allergy diagnosis and allergen immunotherapy, developed for specialist-led patient pathways.

DIATER molecular immunotherapy research imagery

From identifying the allergen to personalised treatment.

DIATER develops and manufactures products for allergy diagnosis and treatment. Its diagnostic portfolio supports specialist investigation through approaches including prick testing, intradermal testing and professional evaluation of beta-lactam allergy.

The immunotherapy portfolio spans subcutaneous, intradermal and sublingual pathways, including molecular immunotherapy developed around purified native allergens.

01

Allergy diagnosis

Diagnostic products for prick testing, intradermal venom testing and beta-lactam allergy evaluation in professional practice.

02

Molecular immunotherapy

A precision approach based on purified native allergens and specialist selection of the relevant treatment pathway.

03

Treatment formats

Subcutaneous, intradermal and sublingual immunotherapy options developed for different clinical and patient needs.

DIATER diagnostic and immunotherapy products require qualified professional assessment, prescribing or administration as applicable. Availability, indications and regulatory status vary by market.

Diagnosis to treatment

A specialist allergy pathway.

Official DIATER imagery representing professional skin testing and allergen immunotherapy.

Healthcare professional performing a skin prick test
Professional allergy diagnosis
Healthcare professional administering subcutaneous immunotherapy
Specialist-led allergen immunotherapy

DIATER enquiries

Talk with us about diagnosis and immunotherapy in ANZ.

Contact MAG Pharma